---
title: "BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update | BCLI Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286606968.md"
description: "BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update | BCLI Stock News"
datetime: "2026-05-15T12:05:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286606968.md)
  - [en](https://longbridge.com/en/news/286606968.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286606968.md)
---

# BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update | BCLI Stock News

BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update | BCLI Stock News

### Related Stocks

- [BCLI.US](https://longbridge.com/en/quote/BCLI.US.md)

## Related News & Research

- [Palvella Therapeutics CEO joins Canaccord Genuity Growth Conference fireside chat](https://longbridge.com/en/news/294958978.md)
- [Spero Therapeutics CMO Debra Zack files initial beneficial ownership statement](https://longbridge.com/en/news/295153314.md)
- [Strawberry Fields REIT declares Q3 cash dividend of $0.17 per share](https://longbridge.com/en/news/295151088.md)
- [Heron Therapeutics (HRTX) Projected to Post Quarterly Earnings on Monday](https://longbridge.com/en/news/294710967.md)
- [Full Transcript: Palvella Therapeutics Q2 2026 Earnings Call](https://longbridge.com/en/news/294837772.md)